Kalibrate Blockchain is a Title III - Regulation Crowdfunding Campaign and is actively accepting investments.
$100.00 minimum investment

Kalibrate Blockchain

Filling Forms to Index Healthcare

Small OPO
Altamonte Springs, FL
Health Tech
Accepting International Investment
Play video

The UNIVERSAL PATIENT INDEX is the blockchain platform that resolves patient identity across healthcare.

Click the clipboard goodbye!

Introducing FormDrop mobile app


Patients universally dislike filling out forms on clipboards. 


Despite more than a decade of significant investments in Electronic Health Record (EHR) technology, patients in the United States are still handed millions of clipboards with paper forms on them each year. In this age of clicks and taps, patients wonder why they're still handed clipboards, paper forms, and pens or electronic tablets most of the time and be expected to remember and provide important personal health information whenever they seek healthcare services.


As currently envisioned, the FormDrop mobile app will solve this problem by allowing you to use your smartphone to automatically fill out any form, anywhere, made by anyone.


Just click on the image using your mobile device camera, and Kalibrate Blockchain's FormDrop app will use human-augmented artificial intelligence to fill out the form and fax or email it to the medical records specialist at your healthcare provider's office. Where does the information come from?


FormDrop will use information previously stored in your personal Digital Health Wallet and indexed on the Universal Patient Index blockchain.


Each time you fill out and submit a form via FormDrop, any new information you provide on that form will be securely stored in your Digital Health Wallet, and your Patient ID associated with that form will be indexed on the Universal Patient Index for future use and easy retrieval. While filling out the new form, you can add new information or update existing information that has previously been indexed.


Your Digital Health Wallet will allow you to fully control access to your personal health information.


When you claim your personal Digital Health Wallet, you will gain full control of your personal health information accessible via the Universal Patient Index. Your Digital Health Wallet, which operates based on the Undiscoverable Association Protocol, will be your go-to tool for quickly and securely sharing personal health information with requesting healthcare providers.        

The Universal Patient Index is being developed to solve the chronic and persistent problem of resolving Patient IDs across healthcare information systems.


Additionally, Kalibrate Blockchain is developing a suite of products that serve as gateways to the emergence of the Universal Patient Index including:


  • FormDrop (form-filling app and minimum viable product)

  • Digital Health Wallets (patient-sovereign personal health index distributed application)

  • KalibrateMe (personal blood testing kit)

  • KalibrateV (personal vitamin system & blood testing kit)

  • KalibrateC (Warfarin-derived drug with embedded blood testing kit)

  • KalibrateCoin (cryptocurrency utility tokens driving emergence of the Universal Patient Index and operation of its associated products)

This solution will put patients in control of their own health information while offering new opportunities for health enterprises to communicate with patients both inside and outside of their networks.

Development Stage

The Company is currently in the development stage of the project. No products or services have been launched into the market as of the date of this offering. FormDrop (which is the Company’s minimum viable product) and Kalibratev are in active development and are approaching their beta testing phases.


This Project Timeline represents the Company’s current views and is subject to revision based on conditions and circumstances.


The Offering

Investment
$0.40 per Unit, comprised of One share of Common Stock and One option to purchase One Kalibrate Coin.


When you invest, you are betting the company’s future value will exceed $19 million.


Option Terms

Options may be exercised at the price of $1.00 at any time after a bona fide transaction, pursuant to which the Company sells and issues Kalibrate Coins to the general public in a publicized offering. Options shall expire if not exercised on December 31, 2025.  




Kalibrate Coin

Description: Kalibrate Coin represents the right to use the Universal Patient Index. It will be used to compensate the autonomous computing agents that serve the Universal Patient Index. Kalibrate Coin, as currently envisioned, will be used to purchase the products and services associated with the Universal Patient Index including Kalibratev, KalibrateMe and KalibrateC. Kalibrate Coin will be a digital token created by smart contracts. The Company expects to create Kalibrate Coins on the Ethereum blockchain network, and it may, at some future date, be transferred to some other blockchain.


The Universal Patient Index system will require utility tokens called Kalibrate Coins to create incentives for autonomous agents or “players” to operate its blockchain-based distributed autonomous network. As currently contemplated, Kalibrate Coin will be a utility token offered at an unspecified future time.


Blockchains rooted in ecosystems nurtured by utility tokens are inherently suited to solve the classical network problem. The Company’s utility token, Kalibrate Coin, if issued, will be used to obtain access to services, pay for the costs of delivering services, and sell goods associated with the Universal Patient Index. As currently contemplated, a limited number of utility tokens will be issued and used in the Universal Patient Index system.


The Company anticipates that the resulting cryptoeconomy will provide ongoing motivation among healthcare enterprises, providers, and patients to participate in the Universal Patient Index to their ultimate long-term benefit. The Company believes that such participation will contribute to a network effect whereby use of the Universal Patient Index will become more valuable as increasing numbers of healthcare enterprises, providers, and patients continue to adopt the Universal Patient Index, creating increased demand for the Universal Patient Index and its associated products and services.


The right to tokens is contingent upon the successful development of such tokens and to the extent applicable, the blockchain upon which they function. There is no guarantee that successful development will ever occur.

Pressing Need Recognized for Patient ID & Biometric Matching Across Healthcare 

The need for a universal means to accurately and efficiently match patient ID’s and patient biometrics across healthcare is well documented in both health information technology and health management literature.


In 2017, The College of Healthcare Information Management Executives described it as a “serious problem,” and in 2015 it stated that “unintended injury attributable to patient data-matching error is a considerable and growing problem in this era of health information exchange… Despite years of development, no clear strategy on patient matching has emerged.”

 

In February 2018, the New England Journal of Medicine made the following claim in an article published on its website:


“Developing a unique patient identifier system would have many benefits. When accurate information is attached to the right patient, data access is timelier for clinical, administrative, quality improvement, and research purposes; inappropriate care, redundant tests, and medical errors are reduced; and health information exchange becomes easier — within organizations as well as between. Identifiers are also beneficial for patient mobility, allowing information to be linked to patients and following them as they move.”


Extensive time and effort are spent during the patient registration process to gather patient identity information. It is particularly difficult and time-consuming to gather enough information with each transaction to match patient ID’s across master patient indexes (MPI's) to the level of accuracy required by insurance, pharmacy, and clinical systems. This represents significant redundancy of effort, risk of error, and loss of time by patients and healthcare providers alike. 


In fact, the patient registration and identity verification process, which is central to every episode of healthcare delivery, is one of the most pervasive, time-consuming, labor-intensive nonclinical efforts undertaken by healthcare providers. Those processes continue to be among the most dominant and inefficient support processes in healthcare.


The matching of Patient ID’s across healthcare transactions is essential to many core healthcare functions including billing, private information exchange, and authorization for treatment or procedures. 


Current health IT systems rely primarily upon demographic data such as name, birth date, and billing addresses to match Patient ID’s. This strategy matches Patient ID’s with 90 to 95 percent accuracy, but, scaled to population, results in unacceptably high numbers of duplicate but inconsistent records that need to be corrected or merged, with high risk for error that has the potential to negatively impact medical outcomes. 


According to the Rand Corporation, the “lack of a [universal patient identifier] prevents the health care system from achieving full automation and connectivity and its full clinical, public health, and research potential because it is dependent on non-ambiguous linking of patients and records.” In fact, Rand Corporation has estimated that effective private health information exchange between healthcare providers would realize more than $77 billion in efficiency savings alone and potentially more than double this figure in terms of improved clinical outcomes and patient safety. 


Recent efforts to adopt sophisticated electronic health records systems (EHR's) and drive system interoperability have been inefficient and inaccurate in matching Patient ID’s across multiple independent enterprise MPI's. Numerous entities have sought to solve the Patient ID problem specifically. They have failed to solve the problems of time consumption, inefficiency, and introduction of Patient ID errors that continue to plague healthcare. 


Early proponents of assigning each patient a unique numerical identifier failed to overcome objections that such an identifier would potentially expose patients to hacking, fraud, and unacceptable risk that private data might be compromised. Accordingly, in 1998, patient privacy advocates lobbied Congress to pass Public Law 105-277, which prohibits the Department of Health and Human Services from allocating federal government resources to “promulgate or adopt any final standard… providing for the assignment of a unique health identifier for an individual… until legislation is enacted specifically approving the standard.” 


In 2017, the College of Healthcare Information Management Executives (CHIME) recognized patient identity as a “serious problem in healthcare” (Siwicki). According to the American Health Information Management Association, the average medical record duplication rate is between 8 and 12 percent. Accordingly, CHIME sponsored an industry-wide competition for the purpose of “incentivizing innovators to create a solution for ensuring 100 percent accuracy in identifying patients in the U.S.” (Siwicki).


The College of Healthcare Information Management Executives (CHIME) Healthcare Innovation Trust considered accurate patient identification “fundamental to patient care today.” 


As such, CHIME hosted a $1 million National Patient ID Challenge in 2016 to stimulate the creation of a “nationwide patient identification solution.” It set extremely high standards for the contest in terms of potential situations and use cases. No contestant was able to clear all of the hurdles.

Two years later, when no workable solutions had emerged from the CHIME Challenge, the organization suspended the contest stating, “we remain committed to finding a solution that accurately identifies a patient 100 percent of the time, and we will use our position as a leader to bring together key stakeholders and double down our efforts.”  


According to Ben Moscovitch, manager of health information technology at The Pew Charitable Trusts, “the CHIME challenge helped underscore the importance of patient identification and matching in fostering the interoperable exchange of health data, and the difficulty in addressing this perennial problem in healthcare” (Siwicki).


While many powerful technology companies have recognized the need and created related products, a satisfactory solution has remained elusive—until now. For more than 30 years, the Company’s founder Calvin Wiese has been actively seeking a universal patient identity solution that was originally envisioned and authorized by HIPAA but eventually abandoned and defunded due to patient privacy concerns that were, until now, unsolvable. Recently emerging blockchain technologies allow for the development of viable universal solutions to previously unsolvable problems.


Patients wander in and out of various health networks for various reasons. They wander around the healthcare universe seeking various health-related products and services. Every place they seek those products and services, they leave behind nodes of information distributed throughout the health information universe. Only patients know where they have been in the healthcare universe. 

 

Patients currently have little control over the information they’ve distributed across the health information universe, yet hospitals and doctors largely rely on patients to be the indexes of that information. Accordingly, at each point of service, good medical practice requires healthcare providers to interrogate patients about their own health-related events as well as about the healthcare products and services they have consumed to that point. Through imperfect, inefficient, and redundant processes, doctors and hospitals seek to gather the scattered nodes of information patients have deposited over years and even decades across the healthcare universe.  

 

Filling out forms is a widely-used method for interrogating the patient/index, but the problem remains that patients are poor indexes of their own health information. They are forgetful and make errors in filling out forms. Doctors understandably interrogate patients with skepticism because patients are error-prone indexers. 


Kalibrate Blockchain has, for the past two years, been engaged in researching and developing the Universal Patient Index to address the well-known, well-defined, pervasive, and expensive problem of Patient ID matching. Kalibrate Blockchain expects to accomplish this purpose without creating a centralized database that itself would be vulnerable to hacking or privacy infringement. Such databases have already proved to be unfeasible solutions to problems of Patient ID matching among healthcare enterprises and providers.


Kalibrate Blockchain is incorporating a patent-pending blockchain process into the Universal Patient Index that detects duplicate patient identities. The blockchain Universal Patient Index efficiently, accurately, and securely matches Patient ID's across health information transactions and enterprise boundaries.


Kalibrate Blockchain's primary goal for the Universal Patient Index is to lower barriers between existing MPI's currently used by every healthcare enterprise. The Universal Patient Index achieves this by associating Patient ID’s with deterministic hierarchical keys stored in token-operated, patient-sovereign Digital Health Wallets that detect and merge these duplicate identities within the Universal Patient Index. 


Kalibrate Blockchain's Undiscoverable Association Protocol will make Patient IDs indexed on the Universal Patient Index invulnerable to malicious or surreptitious attack. 


The Universal Patient Index will be patient-sovereign rather than owned by any proprietary interests, an inherent quality of blockchain technology that extends nicely to the realm of patient sovereignty in healthcare. Cross-referencing Patient ID’s across MPI’s to facilitate exact matching has been unattainable and unacceptable until now due to patient privacy protections. Kalibrate Blockchain's Undiscoverable Association Protocol, as currently envisioned, eliminates the privacy threats previously thought insurmountable.


Kalibrate Blockchain's leaders and developers believe that the Universal Patient Index is the best solution to the Patient ID matching problem. It meets 26 of the 27 criteria defined in the CHIME rubric used in its widely-publicized National Patient ID Challenge (see rubric below). 


The Universal Patient Index will augment the efforts of patients to index their own health information, equipping them to more easily fulfill their indexing role in healthcare. It will make indexing more reliable for doctors. It will automate filling out forms and make form-filling easy and accurate. Ultimately, it will yield better and more accurate information that will lead to better and safer patient outcomes.

Universal Patient Index EMERGENCE Strategy Driven by High-Demand Consumer Products and Cryptocurrency

Kalibrate Blockchain is developing an enticing array of high-demand consumer products to drive its emergence strategy for the Universal Patient Index.


Consumer use of these products will result in more patient health information being indexed on the Universal Patient Index. As such, emergence of the index will not depend on provider adoption, but rather will be driven by consumer demand for a compelling suite of products that will provide patients with sovereign control over their own health information.


Consumer-driven emergence will set Kalibrate Blockchain apart from other similar projects that have failed to overcome adoption hurdles. 


Other products in the suite will be developed by companies related to Kalibrate Blockchain. A portion of the proceeds from this and the expected Regulation D and Regulation S offerings will be invested in these companies to help fund the development of these products.


The launch of FormDrop is expected to be concurrent with the offering of Kalibrate Coin cryptocurrency.


The Units in this Offering include both shares of Common Stock and options to purchase Kalibrate Coins under a future offering. Kalibrate Blockchain leaders believe that the envisioned Kalibrate Coin offering will attract significant interest in the United States as well as in international markets.


As currently envisioned, Kalibrate Coin will be offered as a utility token.  


The Kalibrate Coin Offering is expected to occur simultaneously with the public launch of FormDrop, which requires Kalibrate Coin to operate. As such, the consumptive use of the Kalibrate Coins is expected to exist at the time of the utility token offering.


Kalibrate Coin utility tokens will be implemented to drive use of the Universal Patient Index and its associated products.


The future Kalibrate Coin Offering will be used to incentivize the operation of the Universal Patient Index blockchain as well as to acquire access to its services and to purchase the products and services that support and fuel the emergence of the Universal Patient Index.


Kalibrate Coin is expected to be issued on an existing blockchain suitable for the issuance of cryptocurrencies, such as the Etherium blockchain.  The envisioned Kalibrate Coin offering will be offered within the United States as well as in international markets.  


The Company believes that this novel approach to offering Kalibrate Coins will have unique attractiveness to investors because 1) it will be offered simultaneously in the United States and foreign markets, and 2) consumptive use demand for Kalibrate Coins will already exist when they are issued, and 3) demand for Kalibrate Coins will already exist among hospitals in the United States wishing to fund their FormDrop sponsorships.


Consumer Product Suite

FormDrop, a mobile form-filling app, is a proprietary mobile application being developed and will be operated by Kalibrate Blockchain as a mobile, patient-sovereign health indexing platform. It is the Company’s minimum viable product.

FormDrop will automatically fill out any form—anytime and from anywhere—using a variety of information sources including the Universal Patient Index, their own personal information repository, and hospital medical portals. 


The Company believes the distinctive feature that will drive adoption of FormDrop is its universal scope: it will work for any form, anywhere, anytime with no requirement that the enterprise or provider collecting data via FormDrop register or perform any action other than to receive the information by fax or by email on behalf of the patient authorizing the information transfer. 


FormDrop will generate revenue from promotions by sponsoring hospitals targeting patients using the app or seeking healthcare services and by custom targeted medical promotions.

KalibrateV, a personal vitamin system and blood testing kit, will include an embedded, affordable, direct-to-consumer personal blood testing device, mobile app, and a custom blend of multi-vitamins tailored to the individual’s blood test results. Consumers will use the system to conveniently and inexpensively draw and submit their own fingerstick blood samples from the comfort of their own homes.


The kit will include biometric sensors to collect EKGs and iris scans, which will be registered during the blood collection process to ensure positive matches between the patients and their blood samples. These biometrics will be recorded onto the Universal Patient Index to further power the emergence of that index.


KalibrateMe, a personal blood testing kit, will allow consumers to draw their own blood from a finger-prick in the convenience of their home, drop it in the mail, and receive results from a clinically useful panel of 10 to 12 blood tests with clinical precision at a very low price of $10 to $12.  

This blood testing method will unleash the massive analytical power of mass spectrometry on the high-demand direct-to-consumer blood testing market. 


Market research by C3Research, LLC, indicates that demand in the US market for direct-to-consumer blood testing exceeds $9 billion per year.


The kit will include biometric sensors to collect EKGs and iris scans, which will be registered during the blood collection process to ensure positive matches between the patients and their blood samples. These biometrics will be recorded onto the Universal Patient Index to further power the emergence of that index.

KalibrateC, a Warfarin-derived drug system with embedded blood test, will make Warfarin therapy safer by allowing patients to test their own Warfarin levels in the comfort of their own homes. This product is currently in development.


Warfarin is the most widely used drug for oral anticoagulation therapy with more than 18 million prescriptions per year in the United States, according to clincalc.com. Its narrow therapeutic window requires routine blood testing to manage. Deviations from the narrow therapeutic window are the dominant cause of hospitalizations related to Warfarin drug therapy.


According to an article published by C.Ruff in December 2013, Warfarin is both the most dangerous high-volume drug used in medical practice and the most widely-prescribed of the most dangerous drugs used in clinical practice. In fact, the Institute of Medicine has identified Warfarin as the most implicated drug in adverse drug events resulting in hospital admissions from emergency departments.  


Adverse drug events are important preventable causes of hospitalization in older adults. According to a November 2011 study cited in Emergency Hospitalizations for Adverse Drug Events in Older Americans, 33.3% of all adverse drug event hospital admissions from emergency departments are related to Warfarin therapy—that’s more than 33,000 hospitalizations annually in the United States.  


A top-tier, peer-reviewed, randomized, prospective, double-blind, clinical study performed by top-tier scientists demonstrated (p=.037) that Warfarin is six times safer when monitored with a novel blood test instead of the universally used INR blood test. The study, published in the journal Blood on January 15, 1990, was based on a randomized prospective trial comparing the native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant therapy. 


The new KalibrateC system will combine a derivative of the Warfarin chemical entity with a dosage surveillance and medication administration system associated with the Universal Patient Index and Digital Health Wallets. The KalibrateC blood sample collection kit and mobile app will be used by patients to conveniently and inexpensively draw and submit their own fingerstick blood samples in the comfort of their own homes. 


The kit will include biometric sensors to collect EKGs and iris scans, which will be registered during the blood collection process to ensure positive matches between the patients and their blood samples. These biometrics will be indexed onto the Universal Patient Index to further power the emergence of that index.

The KalibrateC monitoring system is designed to be used weekly by patients undergoing Warfarin therapy. Patients will draw their own blood using a simple KalibrateC finger-prick personal blood test and then deliver the blood sample to the lab via regular mail. Inputs from these blood tests will be calculated using KalibrateC’s dosing algorithm, resulting in recommended dosing modifications and updates to the medication administration system that prompt the patient to take the correct dose at the prescribed time. Blood test values and dosing modifications will be explained to the patient using KalibrateC’s edutainment and media assets designed to propagate adherence-reinforcing interactions.


KalibrateC will be priced to cover costs associated with monitoring and dosage recommendations. Kalibrate Blockchain expects that the system will be priced higher than Warfarin alone but significantly lower than the emerging class of novel anticoagulants currently competing with Warfarin. 


The company reasonably anticipates that KalibrateC will make Warfarin safer than other oral anticoagulant therapies (p=.037) and significantly reduce Warfarin-related complications such as stroke and hemorrhage. Using the 505(b)(2) FDA new drug approval pathway, a new drug that uses this novel blood test and a derivative of the existing chemical entity can be approved with a high certainty clinical study.


As currently contemplated, the adoption of KalibrateC will be promoted using the FormDrop app’s prescient moment sponsorship promotions. As such, when a patient using FormDrop to fill out a form indicates that Coumadin is being used, that patient will receive a targeted message introducing KalibrateC as a safer option for Coumadin monitoring and treatment, which the patient can then discuss with his or her doctor.

Fast-Growing HIE and Blockchain Markets

North America health information exchange market, by set up type, 2013-2024 (USD Million). The global health information exchange market was valued at USD 988.6 million in 2015.

SOURCE: https://www.grandviewresearch.com/industry-analysis/health-information-exchange-hie-market

Kalibrate Blockchain is a unique competitor in the swiftly growing health information exchange (HIE) technology market.  


Demand is growing quickly for technology platforms that facilitate management of vast amounts of healthcare data. Governmental organizations increasingly focus on the promotion of healthcare information technology to improve the quality of healthcare services. Challenges with regard to patient identity and patient health information exchange remain unsolved in this growing market, which is also driven significantly by the ongoing need of healthcare enterprises to decrease costs associated with maintaining paper-based patient health records.


Blockchain is a highly-regarded solution space and growing market for tech products that resolve problems in patient identity and health information exchange.


Digital identity is expected to be the fastest-growing application in the blockchain market because it eliminates the need for a central authority and third parties, thereby making it easier for the individuals to manage and control over personal information and access, according to market studies by P&S Intelligence and MarketsandMarkets.com. The blockchain market is expected to reach $23.3 billion by 2023, according to a MarketsandMarkets.com study.


The Universal Patient Index and its associated products will be highly attractive commercially feasible solutions to patient identity and health information exchange problems.



The global blockchain market is projected to grow at a CAGR of 80.2% from 2018 to 2023.


SOURCE:  https://www.marketsandmarkets.com/PressReleases/blockchain-technology.asp

Our Leadership Team

The Kalibrate Blockchain leadership team has rich experience and skill in business problem-solving, technology, team-building, finance, creativity, and innovation. 


CEO Calvin Wiese has worked with Alan Dowling and CFO Gary Skilton in healthcare and technology for more than 30 years. During the 1990s Calvin and Gary lead the financial management of Adventist Health System (now known as Advent Health) fueling its growth from $1 billion to $3 billion and that now exceeds $20 billion. This management team was widely recognized for finding innovative solutions to chronically persisting problems, many of which were adopted throughout the healthcare industry. The cover story for the June 1999 issue of HealthCare Finance profiled many of their accomplishments and included the following quote from Standard & Poor's:

"Calvin and his staff...are just a lot more sophisticated than most hospitals or hospital systems."



Alan Dowling has been a significant leader in healthcare information for nearly 40 years. With a PhD from MIT in Healthcare Computer Science, Alan has served in many of the most prestigious positions in healthcare information, including director of healthcare information technology at Ernst and Young and CEO of the American Health Information Management Association. Dowling has also served on numerous boards and commissions in the government and military including the Clinton Administration’s Healthcare Reform Task Force. Wiese and Dowling led the development of one of the earliest personal health record systems to be deployed over the internet that focused on patient-sovereign health information and patient identity management. Dowling continues to provide leadership in healthcare information including serving as Health Informatics Consultant to Inter-American Development Bank (2018) and teaching healthcare information classes at Case Western Reserve University.

Staffing Approach

The Company is employing a “lean start-up” methodology that adapts lean management principles to high tech startup companies and seeks to measure demand through close interaction and feedback from early adopters. Accordingly, it is the Company’s intent to streamline its business plan, eliminate wasteful practices, produce increased value during the development phase, iteratively build its products and services to meet the needs of early customers, and reduce market risks through reliance on key performance indicators and early customer feedback. It will achieve these ends by developing a minimum viable product that can be tailored to the specific needs of its users and customers with minimal investment of time and resources.

 

An important aspect of the Company’s lean start-up methodology is its approach to managing labor costs. The diverse and high-tech nature of its products and services demand a team with a wide array of specialized skills and competencies. Acquiring such skills and competencies in a start-up project can quickly result in very high labor costs. The Company’s approach is to avoid purchasing more labor than is required by working on a contract, as-needed basis with individuals who possess the skills and competencies needed to complete the Project in a cost-effective, timely manner. Most of the individuals currently contracted by the Company on an as-needed basis are prepared to engage in full-time employment as the Project needs increase to the point that their services are needed on a full-time basis. Calvin Wiese engages substantially all of his time working for the Company and its associated projects, and the Company is his primary responsibility. Gary Skilton currently spends between 10 and 15 hours a week working for the Company. The Company is his primary responsibility, and he is available to devote substantially full time as the Company requires. Larry Hufty currently spends between 10 and 15 hours a week working for the Company and is available to devote 35 to 40 hours a week as the Company requires.

Invest in Kalibrate Blockchain Today!

Kalibrate Blockchain is solving significant patient identity and health information exchange problems in profound and systematic ways.


Kalibrate Blockchain's transformative solutions to health information access and exchange problems are physically possible, appropriately supported, and financially feasible, with potential to result in the highest value. They are believed to represent the highest and best use for blockchain in healthcare.



As an investor, this is your opportunity to contribute to profound developments that can transform the way health information is indexed,  accessed, and exchanged so that healthcare providers have the information they need to innovate and provide patients with the best possible care.
 It's an opportunity to personally benefit while creating positive change in healthcare.

The Units in this Offering include both shares of  Common Stock and options to purchase Kalibrate Coins under a future ICO Offering. 


The future Kalibrate Coin Offering will be used to incentivize the operation of the Universal Patient Index blockchain, as well as to acquire access to its services and to purchase the products and services that support and fuel the emergence of the Universal Patient Index.

Kalibrate Blockchain's press releases about product and company developments have been picked up by literally hundreds of national and global media outlets over the past year, including mainstream, business, and tech media. Pundits and commentators have identified Kalibrate Blockchain as a major new player in the health information and blockchain solution space.


In the Press

Kalibrate Blockchain Developing Universal Patient Index
April 22, 2018

Kalibrate Blockchain is developing a universal patient index to personal health information. It will also launch its Kalibrate Coin cryptocurrency, which will monetize digital rights to medical data and incentivize use of the blockchain index by patients and providers.

Kalibrate Blockchain Adopting Charter for Fully-Autonomous Patient Index; Commonly-Curated Index Solves Key Health Information Transaction Issues
June 29, 2018

Kalibrate Blockchain, Inc., is adopting a charter to develop a commonly curated, fully autonomous Universal Patient Index. The Index will be universally accessible without limitation by enterprise or political boundaries. It overcomes the biggest challenge in the health information world.

Kalibrate Blockchain Universal Patient Index For Health Identities & Tracking Issues
June 30, 2018

Kalibrate Blockchain, Inc., is developing a commonly curated, fully autonomous Universal Patient Index that facilitates rapid, efficient binding of patient health identities across healthcare transactions without limitation by enterprise or political boundaries—a big deal for healthcare enterprises.

Kalibrate Blockchain Patenting Process to Eliminate Duplicate Patient Identities
August 14, 2018

Kalibrate Blockchain, Inc., has filed an application to patent a process that eliminates duplicate patient index identities. The patent-pending process is an essential attribute of the Universal Patient Index currently being developed by the company.

Kalibrate Blockchain To Offer Exclusive Licenses to Embed FormDrop SDK in Hospital Mobile Apps
February 12, 2019

Kalibrate Blockchain, developer of the Universal Patient Index, will kick off an exclusive licensing program for its FormDrop mobile app at the HIMSS19 Conference on Tuesday, February 12, 2019, in Orlando's Orange County Convention Center.

Kalibrate Blockchain Offers Hospitals Exclusive Licenses To Its Mobile Apps
February 15, 2019

Kalibrate Blockchain, a firm that is engaged in indexing healthcare with blockchain, announced at the Healthcare Information and Management Systems Society Conference (HIMSS) in Orlando, Florida that it will begin an exclusive licensing program for its FormDrop mobile app.

New Blockchain-Powered Tech Explored at HIMSS19
February 12, 2019

Kalibrate Blockchain, Boehringer Ingelheim and IBM Canada all are working with blockchain-based technologies designed to improve and secure healthcare processes, including clinical trials.

Video: At HIMSS19, Kalibrate Blockchain to offer exclusive licenses to embed FormDrop SDK in hospital mobile apps
February 13, 2019

Kalibrate Blockchain, developer of the Universal Patient Index, launched an exclusive licensing program for its FormDrop mobile app at the HIMSS19 Conference on February 12 in Orlando. The company will award an exclusive FormDrop SDK license to a single hospital in each market.

Blockchain-Based App Allows Patients to Submit, Access Health Information
February 13, 2019

Kalibrate Blockchain is rolling out a new program for hospitals in various markets that allows them to license its mobile app, FormDrop. FormDrop, which is built on a blockchain, allows patients to electronically fill out and submit necessary health information to providers.

Kalibrate Blockchain To Offer Exclusive Licenses to Embed FormDrop SDK in Hospital Mobile Apps
February 15, 2019

Kalibrate Blockchain will award an exclusive license to a single hospital in each market allowing that hospital to embed the FormDrop SDK in its own mobile app.

4 Main Takeaways From HIMSS19
February 15, 2019

Digest the biggest health IT conference of the year with what grabbed the attention of more than 43,000 health execs, policymakers and academics. New blockchain tech explored at HIMSS includes names like Kalibrate Blockchain, which introduced its exclusive licensing program for its FormDrop app.

Is It Possible to Improve Healthcare with Blockchain Technology?
February 20, 2019

The FormDrop app allows patients to electronically fill out and submit forms to healthcare providers using their personal smartphones, with no need for clipboards, paper forms, or electronic tablets. Patients can also use FormDrop to index their patient ID’s and personal health information.

Offering Summary

Maximum 2,675,000* Units ($1,070,000)

*Maximum subject to adjustment for bonus shares. See 10% Bonus below

Minimum 25,000 Units ($10,000)


Company
Kalibrate Blockchain Corporation
 

Corporate Address
378 CenterPointe Circle, Suite 1208,  Altamonte Springs, FL 32701
 

Description of Business
The Company is developing the UNIVERSAL PATIENT INDEX that is the blockchain platform for resolving patient identity across healthcare.  It is the missing link essential to every healthcare transaction.  It solves the root cause of much of what ails healthcare information.
 

Type of Security Offered
Units, consisting of one share of Common Stock and the option to purchase one Kalibrate Coin
 
Purchase Price of Security Offered
$0.40
 

Minimum Investment Amount
 (per investor) 
$100












Terms of the Options 

Each option grants the right to purchase one Token (as defined below) at a price per Token equal to $1.00.  The Option may be exercised by the Purchaser at any time after a bona fide transaction, pursuant to which the Company sells and issues Tokens to the general public in an offering (the “Network Launch”), however, this Option shall expire on December 31, 2025.  


Terms of Tokens

Token means a digital token in the form of a Smart Contract that is executed on a decentralized blockchain-based computer network that is used to access rights to services on the distributed autonomous network that the Company is developing to instantiate the universal patient index.  The Network Launch of this Token is expected to be undertaken at a time when the Company’s minimum viable product is available for public use; provided, however, there is no guaranty that the Token or the network will ever be developed or launched.  Tokens issued to US entities will carry exchange restrictions that will prevent such Tokens from being exchanged for money.  These exchange restrictions will be enforced either by (1) encoding the exchange restrictions into the Smart Contract, or (2) issuing a separate class of Tokens.  For purposes hereof, “Smart Contract” means a computer protocol intended to digitally facilitate, verify, or enforce the negotiation or performance of a contract.


Kalibrate Coin

Description:  The Token, Kalibrate Coin, will represent the right to use the Universal Patient Index.  It will be used to compensate the autonomous computing agents that will serve the Universal Patient Index. Using the Token, as currently contemplated, holders will be able to purchase the products and services associated with the Universal Patient Index including Kalibratev, KalibrateMe and KalibrateC.  The Token will be a digital token created by smart contracts. The Company expects to create its Tokens on the Etherium blockchain network, and it may, at some future date be transferred to some other blockchain.

The Universal Patient Index system will require utility Tokens to create incentives for autonomous agents or “players” to operate its blockchain-based distributed autonomous network. As currently contemplated, the Tokens will be a utility token offered via an initial coin offering (ICO) at an unspecified future time.

The Company has not authorized or issued any Tokens.  

The Company has granted 11,890,281 rights to future Tokens that will be issued upon its Network Launch.

The Company is planning to initially publicly issue its Tokens in connection with the launch of FormDrop, its minimum viable product which requires Tokens to operate. The prevailing interpretation of US security regulations is inconsistent with US persons exchanging Tokens, and, as such, the Company expects to restrict Tokens purchased by US persons from exchanging Tokens for money.  Such restrictions are expected to be either enforced in the Smart Contract instantiating the Tokens, or, by issuing such Tokens as a separate restricted class.

The Tokens are expected to have no rights to vote, no rights to dividends, no rights to distributions and no redemption rights.

The Company currently does not have a functional distributed ledger based business model nor a blockchain based token and there is no guarantee that such will be developed in the future. The promise of future tokens is contingent upon the successful development of such items.  There is no guarantee that successful development will ever occur.  The right to receive future tokens and the offering of future tokens is being offered as part of this offering exempt from registration under Regulation CF.  

Tax Advisory: Investors should consult their tax advisors with respect to the tax basis for each of the shares of Common Stock and the Tokens, since they will trade independently.

No Sales in New York:  Because the Tokens may be viewed as “virtual currencies” under the laws of the State of New York,  we are not offering the Units to investors in New York.  No Investor who (i) resides, (ii) is located, (iii) has a place of business, or (iv) is conducting business (any of which makes the Investor a “Resident”) in the state of New York will be accepted in this offering.


The 10% Bonus for StartEngine Shareholders

Kalibrate Blockchain Corporation will offer 10% additional bonus units for all investments that are committed, within 24 hours of this offering going live, by StartEngine Crowdfunding Inc. shareholders who invested over  $1,000 in the StartEngine Reg A offering which closed earlier this year.

StartEngine shareholders who invested $1,000 or more in that StartEngine Reg A offering will receive a 10% bonus on this offering within a 24-hour window of this offering’s launch date.  This means you will receive a bonus for any units you purchase.  For example, if you buy 100 units at $1.00 / unit, you will receive 110 units, meaning you'll own 110 units for $100.   Fractional units will not be distributed and unit bonuses will be determined by rounding down to the nearest whole unit.

This 10% bonus is only valid for one year from the time StartEngine Crowdfunding Inc. investors received their countersigned StartEngine Crowdfunding Inc. subscription agreement.

Irregular Use of Proceeds

Irregular Use of Proceeds. The Company expects to incur Irregular Use of Proceeds that may include regular compensation for services by officers and significant shareholders and payments for services provided by related companies. The Company expects to use portions of the proceeds for the development of products and services to drive the adoption of Universal Patient Index to fund such activities of related parties, including Kalibratev, Inc. These activities will be funded through various means that may include loans, operating agreements, development agreements and purchases of equity.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$0.00 USD
$0.00 USD
Cash And Cash Equivalents
$0.00 USD
$0.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$0.00 USD
$0.00 USD
Long Term Debt
-$487.00 USD
$0.00 USD
Revenues And Sales
$0.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$487.00 USD
$0.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Thank you!

19 days ago

Dear Investor!

Thank you for believing in us and for helping us reach 30% of our minimum goal! 

We're committed to the following goals:

  • Solving patient identity issues in healthcare and health information. (The ECRI Institute listed patient identification errors among the top 10 patient safety dangers in 2017!)
  • Putting patients in charge of their own health information. (The role of the clinician or provider as the “protector” of patients’ health information is in question with increasing numbers of patients interested in taking control of their own health records.)

We have a ways to go and are confident in reaching our goals for this campaign! We'll keep you updated.

Meanwhile, tell friends, family, and other potential investors about this opportunity to invest in this campaign for as little as $100!


Have a fantastic day!


-The Kalibrate Blockchain Team

Thank you!

19 days ago

Dear Investor!

Thank you for believing in us and for helping us reach 30% of our minimum goal! 

We're committed to the following goals:

  • Solving patient identity issues in healthcare and health information. (The ECRI Institute listed patient identification errors among the top 10 patient safety dangers in 2017!)
  • Putting patients in charge of their own health information. (The role of the clinician or provider as the “protector” of patients’ health information is in question with increasing numbers of patients interested in taking control of their own health records.)

We have a ways to go and are confident in reaching our goals for this campaign! We'll keep you updated.

Meanwhile, tell friends, family, and other potential investors about this opportunity to invest in this campaign for as little as $100!


Have a fantastic day!


-The Kalibrate Blockchain Team

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Show More Comments